advancing innovation to save lives

GHTC launches petition calling on world leaders to include R&D in the Global Health Security Agenda

GHTC launched a new online petition calling on world leaders to include clear commitments to strengthening R&D capacity in the 2019-2024 Global Health Security Agenda framework, which is currently under development.
Take Action

Return On Innovation: Learn how global health R&D delivers for your state

Global health R&D matters globally and benefits you locally. Find out how US investments in global health R&D are paying economic and health dividends in your state.

Member Spotlight: Global Health Council

Global Health Council (GHC) is the leading membership organization supporting and connecting advocates, implementers, and stakeholders around global health priorities worldwide.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We bring together more than 25 nonprofit organizations, academic institutions, and aligned businesses to advance policies to accelerate the creation of new drugs, vaccines, diagnostics, and other tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.

Learn more
PATH/Nguyen Ba Quang
GHTC sends letter urging House leaders to bolster BARDA’s authority and resources to combat naturally occurring health threats

GHTC sent a letter to the Chairman and Ranking Member of the House Energy and Commerce Committee encouraging them, through the reauthorization of the Pandemics and All-Hazards Preparedness Act, to ensure the Biomedical Advanced Research and Development Authority (BARDA) has ample resources and authority to address emerging infectious diseases (EIDs), pandemic influenza (PI), and antimicrobial resistance (AMR). The letter specifically calls for the creation of a separate funding line of $300 million for EIDS at BARDA, formalization of BARDA’s AMR workstream, and new reporting requirements on the agency’s work in EIDS, PI, and AMR.

PATH/Will Boase
GHTC WHA statement cited in Homeland Preparedness News

A joint statement developed by GHTC and delivered at the 71st World Health Assembly (WHA) was cited in an article in Homeland Preparedness News.

View All News & Events

Community Event

PATH/Gabe Bienczycki
7th East African Health and Scientific Conference
East African Health Research Commission
Learn More

Member Event

PATH/Will Boase
International Conference on Emerging Infectious Diseases (ICEID)
Centers for Disease Control and Prevention, American Society for Tropical Medicine and Hygiene, Infectious Diseases Society of America, and other partners
Learn More
View All Events
Wanted: Tools to fight murderous mozzies and their deadly diseases

For World Mosquito Day, GHTC is taking a moment to shine a spotlight on the ghastly gang of mosquito-borne diseases and the innovations we need to finish these frightening foes for good.

Read More
PATH/Georgina Goodwin
Research Roundup: Ebola vaccinations in North Kivu, the role of biobanks in research, and a new Zika vaccine candidate

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide